Related references
Note: Only part of the references are listed.Similarities between Inherited Demyelinating Neuropathies and Wallerian Degeneration An Old Repair Program May Cause Myelin and Axon Perturbation under Non lesion Conditions
Rudolf Martini et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Therapeutic potential of neuregulin-1 in cardiovascular disease
Pedro Mendes-Ferreira et al.
DRUG DISCOVERY TODAY (2013)
Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice
Maurizio D'Antonio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
A role for Schwann cell-derived neuregulin-1 in remyelination
Ruth M. Stassart et al.
NATURE NEUROSCIENCE (2013)
A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients
Robert Fledrich et al.
BRAIN (2012)
Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice
Agnes Patzko et al.
BRAIN (2012)
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease
Robert Fledrich et al.
BRITISH MEDICAL BULLETIN (2012)
A Central Role for the ERK-Signaling Pathway in Controlling Schwann Cell Plasticity and Peripheral Nerve Regeneration In Vivo
Ilaria Napoli et al.
NEURON (2012)
c-Jun Reprograms Schwann Cells of Injured Nerves to Generate a Repair Cell Essential for Regeneration
Peter J. Arthur-Farraj et al.
NEURON (2012)
Update on Charcot-Marie-Tooth Disease
Agnes Patzko et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia
T. Kato et al.
MOLECULAR PSYCHIATRY (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
MCP-1/CCL2 Modifies Axon Properties in a PMP22-Overexpressing Mouse Model for Charcot-Marie-Tooth 1A Neuropathy
Bianca Kohl et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Soluble Neuregulin-1 Has Bifunctional, Concentration-Dependent Effects on Schwann Cell Myelination
Neeraja Syed et al.
JOURNAL OF NEUROSCIENCE (2010)
Neuregulin1/ErbB4 Signaling Induces Cardiomyocyte Proliferation and Repair of Heart Injury
Kevin Bersell et al.
CELL (2009)
Excitability properties of motor axons in the maturing mouse
Delphine Boerio et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2009)
Diagnosis, natural history, and management of Charcot-Marie-Tooth disease
Davide Pareyson et al.
LANCET NEUROLOGY (2009)
EVOLUTION OF FOOT AND ANKLE MANIFESTATIONS IN CHILDREN WITH CMT1A
Joshua Burns et al.
MUSCLE & NERVE (2009)
Axonal ion channels from bench to bedside: A translational neuroscience perspective
Arun V. Krishnan et al.
PROGRESS IN NEUROBIOLOGY (2009)
Neuregulin-1, a Key Axonal Signal that Drives Schwann Cell Growth and Differentiation
Carmen Birchmeier et al.
GLIA (2008)
Increase of MCP-1 (CCL2) in myelin mutant Schwann cells is mediated by MEK-ERK signaling pathway
Stefan Fischer et al.
GLIA (2008)
Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A
Eppie M. Yiu et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2008)
Nonmyelinating Schwann cell involvement with well-preserved unmyelinated Axons in Charcot-Marie-Tooth disease type 1a
Haruki Koike et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy
Gerd Meyer zu Horste et al.
ANNALS OF NEUROLOGY (2007)
Evidence for macrophage-mediated myelin disruption in an animal model for Charcot-Marie-Tooth neuropathy type 1A
I Kobsar et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Neuregulin-1 type III determines the ensheathment fate of axons
C Taveggia et al.
NEURON (2005)
The origin and development of glial cells in peripheral nerves
KR Jessen et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Axonal neuregulin-1 regulates myelin sheath thickness
GV Michailov et al.
SCIENCE (2004)
Nerve excitability properties in Charcot-Marie-Tooth disease type 1A
H Nodera et al.
BRAIN (2004)
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease
L Nobbio et al.
NEUROBIOLOGY OF DISEASE (2004)
Neuregulins and the neuromuscular system: 10 years of answers and questions
DL Falls
JOURNAL OF NEUROCYTOLOGY (2003)
Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)
MW Sereda et al.
NATURE MEDICINE (2003)
Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot-Marie-Tooth disease 1A duplication
J Berciano et al.
NEUROMUSCULAR DISORDERS (2000)
Share Paper
